Cal/OSHA Approves the Third Readoption of the Emergency Temporary Standards (ETS)
From Navigating COVID-19
< Previous | Table of Contents | Next > |
---|
Contents
- 1 Provisions that Remain the Same
- 2 Provisions that Remain the Same
- 3 The Definition of Vaccination Status is Removed
- 4 No Set Rules for Close Contact Exclusion
- 5 Specific Rules for COVID-19 Cases
- 6 Persons Who Should Isolate
- 7 Close Contacts – General Public (No Quarantine)
- 8 Face Coverings
- 9 Types of Acceptable COVID-19 Tests Broadened
- 10 Contaminated Surfaces No Longer a Hazard
- 11 Outbreaks and Major Outbreaks
- 12 Returned Cases – Applicable to Outbreaks
- 13 Appendix: California COVID-19 Vaccines Booster Recommendations
On April 21, Cal/OSHA held a public hearing and re-adopted a modified version of the Emergency Temporary Standard (ETS) that originally went into effect on November 30, 2020. According to Cal/OSHA, the third revision takes effect on May 7, 2022 and will remain in effect through December 31, 2022. The revised ETS can be found here. https://www.dir.ca.gov/oshsb/documents/Apr212022-COVID-19-Prevention-Emergency-txtbrdconsider-3rd-Readoption.pdf
The Frequently Asked Questions have also been updated and can be found here. https://www.dir.ca.gov/dosh/coronavirus/Revisions-FAQ.pdf
As a reminder the ETS applies to all employees not covered by Cal/OSHA’s Aerosol Transmissible Disease Standard.
Many of the provisions from the second readoption remain in effect but several significant changes have been made that employers must implement. We have fully reported on each readoption of the ETS and employers can read about all prior ETS revisions above.
The third readoption is the final ETS that Cal/OSHAS can issue on an emergency basis unless Governor Newsome issues another executive order authorizing it. Assuming no executive order is issued, the Board could consider a permanent infectious disease standard for general industry. The April 21, public hearing included significant debate about what a permanent standard would look like. Discussion included whether it would be a permanent infectious disease standard, expansion of the aerosol transmissible disease standard and/or amendment of the Illness Prevention Program (IIPP) standard. We will update this section when, and if, a final, permanent version is introduced.
The third readoption continues Cal/OSHA’s alignment of ETS provisions with the CDPH regarding isolation, quarantine and return to work guidelines.
Cal/OSHA has prepared two (2) fact sheets. The first, is a bullet point checklist of changes to the ETS and can be found here. https://www.dir.ca.gov/DOSH/dosh_publications/COVIDOnePageFS-04-21-2022.pdf The second factsheet summarizes isolation and quarantine guidelines and can be found here. https://www.dir.ca.gov/dosh/dosh_publications/Isolation-and-Quarantine-fs.pdf
Provisions that Remain the Same
Provisions that Remain the Same
The Definition of Vaccination Status is Removed
No Set Rules for Close Contact Exclusion
Specific Rules for COVID-19 Cases
Persons Who Should Isolate
Close Contacts – General Public (No Quarantine)
Face Coverings
Types of Acceptable COVID-19 Tests Broadened
Contaminated Surfaces No Longer a Hazard
Outbreaks and Major Outbreaks
Returned Cases – Applicable to Outbreaks
We expect Cal/OSHA and the CDPH to continue to modify guidelines as circumstances change so check back regularly for updated guidance.
Appendix: California COVID-19 Vaccines Booster Recommendations
COVID-19 vaccine |
Primary vaccination series |
When does a person becomes booster-eligible |
Which vaccine booster dose to receive |
---|---|---|---|
Moderna or Pfizer-BioNTech |
1st and 2nd doses |
6 months after 2nd dose |
Any of the COVID-19 vaccines authorized in the United States may be used for the booster dose, but either Moderna or Pfizer-BioNTech are preferred. |
Johnson and Johnson [J&J]/Janssen |
1st dose |
2 months after 1st dose |
Any of the COVID-19 vaccines authorized in the United States may be used for the booster dose, but either Moderna or Pfizer-BioNTech are preferred. |
World Health Organization (WHO) emergency use listing COVID-19 vaccine |
All recommended doses |
6 months after getting all recommended doses |
Single booster dose of Pfizer-BioNTech COVID-19 vaccine |
A mix and match series composed of any combination of FDA-approved, FDA-authorized, or WHO-EUL COVID-19 vaccines |
All recommended doses |
6 months after getting all recommended doses |
Single booster dose of Pfizer-BioNTech COVID-19 vaccine |
< OSHA ETS Requirements | Table of Contents | OSHA Requirements — Recording and Reporting COVID-19 > |
---|
GET IMPORTANT UPDATES
Michael Sullivan & Associates
Learn more about our services:
SullivanAttorneys.comWorkers’ Comp, Simplified.
Sullivan On Comp